Trial record 1 of 1 for:    MM08-141
Previous Study | Return to List | Next Study

Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01177683
Recruitment Status : Active, not recruiting
First Posted : August 9, 2010
Last Update Posted : February 21, 2018
Hoosier Cancer Research Network
Information provided by (Responsible Party):
Sherif Farag, MB, BS, Hoosier Cancer Research Network

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : January 2018
  Estimated Study Completion Date : February 2018